HUGIN NEWS/UCB TRANSFERS BACK TO RECORDATI THE RIGHTS FOR THE SALE OF CORIFEO

A A

UCB (Nachrichten) announces that it has reached an agreement with Recordati (Nachrichten) to transfer back the sales and marketing rights in Germany of Corifeo, an antihypertensive calcium channel blocker, for a payment to UCB of 10 million euros.
FinanzNachrichten.de